JG
RCKT icon

Jain Global’s Rocket Pharmaceuticals RCKT Stock Holding History

Jain Global’s Portfolio RCKT Stock Details RCKT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$461K Buy
+134,665
New +$448K ﹤0.01% 1229
2026
Q1 		– Sell
-92,058
Closed -$323K – 1568
2025
Q4 		$323K Buy
+92,058
New +$315K ﹤0.01% 937

Other funds holding RCKT

RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
NM
Newtyn Management New York $801M AUM 23.14% 1-Year Est. Return
MC
Maverick Capital Dallas, Texas $11.3B AUM 76.6% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return

Jain Global's RCKT Position: Q2 2026 in Review

Jain Global opened a new position in Rocket Pharmaceuticals (RCKT) in Q2 2026: 134,665 shares worth $461K. The stake represents ﹤0.01% of the portfolio and ranks #1229 among its holdings. This is a return to the name: Jain Global previously reported a position in RCKT as recently as Q4 2025.

Jain Global first reported a position in RCKT in Q4 2025 and has held it in 2 quarters since. 180 funds tracked by Wall St. Rank hold RCKT as of Q2 2026.

  • Jain Global held 134,665 shares of Rocket Pharmaceuticals worth $461K as of Q2 2026.
  • Rocket Pharmaceuticals was a new Jain Global position in Q2 2026.
  • Rocket Pharmaceuticals made up ﹤0.01% of Jain Global's portfolio in Q2 2026, its #1229 holding.
  • Jain Global first reported a position in Rocket Pharmaceuticals in Q4 2025 and has held it in 2 quarters since.
  • 180 funds tracked by Wall St. Rank held Rocket Pharmaceuticals as of Q2 2026.

Based on Jain Global's 13F filing for Q2 2026, filed 14 Aug 2026.